Christine Baeder, chief operating officer for generics and biosimilars at Teva USA and newly named chair of the Association for Accessible Medicines, tells this week’s Video Forum about the threats facing the generic pharmaceutical industry and what should be done to counter them. She also discusses the relatively slow pace of adoption of biosimilars in the U.S., the impact of innovative payment models on the marketplace, and the value that generics represent.
Video Forum: Christine Baeder, Teva USA
Latest
Dollar General Literacy Foundation marks another one-day grant milestone
Foundation Awards Nearly $16 Million to Literacy Programs Across the Country; Grant Amount Surpasses Previous One-Day Record Set in 2025.
Ulta Beauty adds third-party delivery partner
Beauty retailer extends its omnichannel experience through partnership with Uber Eats.
Wakefern restructures its sales and marketing operations
Meleta said the the process is underway, with changes taking effect on May 16
Proposed bill could put New York wines on grocery store shelves
The bill targets full-service, 4,000+ sq ft grocery stores already licensed to sell beer, excluding small convenience stores